New research from Washington State University in collaboration with five other institutions suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes.
The study, published in NEJM Evidence, closes a knowledge gap about who can benefit from the breakthrough technology for diabetes management. Now the preferred treatment option for type 1 diabetes, automated insulin delivery improves glucose control and reduces the burden of managing a lifelong condition for both children and adults.
This study is the largest clinical trial to enroll older adults with type 1 diabetes, a group underrepresented in previous trials for AID devices.
Results showed that the two automated systems significantly reduced the time participants spent with dangerously low blood sugar compared to the non-automated system.
The hybrid closed loop system proved most effective at keeping blood sugar in the target range, with a mean time in range of 74% compared to 67% for the predictive low glucose system and 66% for the sensor-augmented pump.
【MORE】